Carmela Scuderi

Dr. Carmela Scuderi

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
HSHolly A.F. Stessman
Holly A.F. Stessman
MWMarjolein H. Willemsen
Marjolein H. Willemsen
MFMichaela Fenckova
Michaela Fenckova
OPOsnat Penn
Osnat Penn
AHAlexander Hoischen
Alexander Hoischen
TKTjitske Kleefstra
Tjitske Kleefstra

26 May 2009 in Neurology
Verified
Journal Article
Closed access
PDF file
EMEugenio Mercuri
Eugenio Mercuri
SMSonia Messina
Sonia Messina
CBC. Bruno
C. Bruno
MMMarina Mora
Marina Mora
EPE. Pegoraro
E. Pegoraro
EBEnrico Bertini
Enrico Bertini
Background: Congenital muscular dystrophies (CMD) with reduced glycosylation of alpha-dystroglycan (α-DG) are a heterogeneous group of conditions associated with mutations in six genes encoding proven or putative glycosyltransferases.

1 March 2000 in Brain and Development
Verified
Journal Article
Closed access
Maurizio EliaMaurizio Elia
Maurizio Elia
RFRaffaele Ferri
Raffaele Ferri
SMSebastiano A Musumeci
Sebastiano A Musumeci
SGStefano Del Gracco
Stefano Del Gracco
MBMaria Bottitta
Maria Bottitta
JGJean-Claude Grubar
Jean-Claude Grubar

1 April 2019 in The American Journal of Human Genetics
Verified
Journal Article
Open access
VSVincenzo Salpietro
Vincenzo Salpietro
NMNancy T. Malintan
Nancy T. Malintan
ILIsabel Llano-Rivas
Isabel Llano-Rivas
CSChristine G. Spaeth
Christine G. Spaeth
SEStephanie Efthymiou
Stephanie Efthymiou
MHMichael G. Hanna
Michael G. Hanna
VAMP2 encodes the vesicular SNARE protein VAMP2 (also called synaptobrevin-2). Together with its partners syntaxin-1A and synaptosomal-associated protein 25 (SNAP25), VAMP2 mediates fusion of synaptic vesicles to release neurotransmitters. VAMP2 is essential for vesicular exocytosis and activity-dependent neurotransmitter release. Here, we report five heterozygous de novo mutations in VAMP2 in unrelated individuals presenting with a neurodevelopmental disorder characterized by axial hypotonia (which had been present since birth), intellectual disability, and autistic features. In total, we identified two single-amino-acid deletions and three non-synonymous variants affecting conserved residues within the C terminus of the VAMP2 SNARE motif. Affected individuals carrying de novo non-synonymous variants involving the C-terminal region presented a more severe phenotype with additional neurological features, including central visual impairment, hyperkinetic movement disorder, and epilepsy or electroencephalography abnormalities. Reconstituted fusion involving a lipid-mixing assay indicated impairment in vesicle fusion as one of the possible associated disease mechanisms. The genetic synaptopathy caused by VAMP2 de novo mutations highlights the key roles of this gene in human brain development and function.

28 February 2017 in Brain
Verified
Journal Article
Open access
PDF file
MZMassimo Zollo
Massimo Zollo
MAMustafa Ahmed
Mustafa Ahmed
VFVeronica Ferrucci
Veronica Ferrucci
VSVincenzo Salpietro
Vincenzo Salpietro
FAFatemeh Asadzadeh
Fatemeh Asadzadeh
EBEmma L. Baple
Emma L. Baple
PRUNE is a member of the DHH (Asp-His-His) phosphoesterase protein superfamily of molecules important for cell motility, and implicated in cancer progression. Here we investigated multiple families from Oman, India, Iran and Italy with individuals affected by a new autosomal recessive neurodevelopmental and degenerative disorder in which the cardinal features include primary microcephaly and profound global developmental delay. Our genetic studies identified biallelic mutations of PRUNE1 as responsible. Our functional assays of disease-associated variant alleles revealed impaired microtubule polymerization, as well as cell migration and proliferation properties, of mutant PRUNE. Additionally, our studies also highlight a potential new role for PRUNE during microtubule polymerization, which is essential for the cytoskeletal rearrangements that occur during cellular division and proliferation. Together these studies define PRUNE as a molecule fundamental for normal human cortical development and define cellular and clinical consequences associated with PRUNE mutation.

1 August 2000 in Journal of Child Neurology
Verified
Journal Article
Closed access
PDF file
Maurizio EliaMaurizio Elia
Maurizio Elia
RFRaffaele Ferri
Raffaele Ferri
SMSebastiano A. Musumeci
Sebastiano A. Musumeci
Simonetta PaneraiSimonetta Panerai
Simonetta Panerai
MBMaria Bottitta
Maria Bottitta
CSCarmela Scuderi
Carmela Scuderi
Numerous neuropathologic and imaging studies have reported different structural abnormalities in the brains of autistic subjects. However, whether or not the degree of brain abnormality is correlated with the severity of developmental impairment in autistic disorder is still unknown. The midsagittal area of the cerebrum, corpus callosum, midbrain, cerebellar vermis, and vermal lobules VI and VII was measured by means of magnetic resonance imaging in 22 boys with low-functioning autistic disorder and in 11 age-matched normal controls. Morphometric measures were statistically compared between groups and correlated with age and scores on the Psychoeducational Profile-Revised and the Childhood Autism Rating Scale. A significant negative correlation was found between midsagittal area of the cerebrum and age in patients with autistic disorder, and a positive correlation was found between the midsagittal area of the midbrain and some sub-scales of the Psychoeducational Profile—Revised. (J Child Neurol 2000;15:504—508).